Statins in the treatment of atherogenic dislipidemia

Journal Title: Terapeutica, Farmacologie si Toxicologie Clinica - Year 2008, Vol 12, Issue 3

Abstract

Statins are the most usefull drugs in the treatment of atherogenic dislipidemia. The benefit of statins was demonstrated in primary and secondary prevention of cardiovascular disease and consists in reduction of major cardiovascular events. The clinical benefit is associated with decreasing in LDL-c levels. New data seems to be needed to establish optimal LDL-c levels in secondary prevention. The benefit is greater and with cost-efficiency in high cardiovascular risk patients. When used in moderate dosage statins are well tolerated drugs but high statins therapeutic regimen is associated with enhanced risk in increasing of liver enzymes levels.

Authors and Affiliations

Maria Rădoi

Keywords

Related Articles

Prognostic score of hyperlactatemia under ART

Background: mitochondrial toxicity is an adverse event of nucleoside reverstranscriptase inhibitors. The biochemical marker is the increased level of serum lactate. Objectives: to identify the risk factors for hyperlacta...

Quantum medicine

BRT is the therapy with electromagnetic oscillations, structures of the organism come into resonance with them. The influence is possible on cellular level as at the level of organ, system of organs and whole body. The...

Strontium - clinical and paraclinical aspects

[b]Introduction:[/b] Stable Strontium -meaning nonradioactive- is nontoxic, even when administered in large doses for prolonged periods. It also appears to be one of the most effective substances yet found for the preven...

Clinical and paraclinical corellations in acute poissoning <br /> with phenobarbital

[b]Introduction:[/b] The acute intoxication with barbiturates, still widely used in medical practice, is a redoubtable matter, especially when long acting compounds are involved; because they have a long half time, slowl...

Blood culture - actual requirements and perspectives

The detection of bloodstream infections (BSI) is one of the most important tasks performed in clinical microbiology laboratory. Rapid and reliable detection of BSI includes identification of pathogens at species level an...

Download PDF file
  • EP ID EP83079
  • DOI -
  • Views 108
  • Downloads 0

How To Cite

Maria Rădoi (2008). Statins in the treatment of atherogenic dislipidemia. Terapeutica, Farmacologie si Toxicologie Clinica, 12(3), 341-348. https://europub.co.uk/articles/-A-83079